Vicore Pharma | Discussion on the IPF landscape
00:00 Intro 00:24 CEO Ahmed Mousa - Overview on Vicore Pharma and the disease IPF 01:34 Dr Francesco Bonella - Introduction and role in the ASPIRE trial 03:09 Unmet needs in IPF 05:32 Number of patients suffering from IPF each year 05:56 Current approved treatments and outlook for patients treated 07:11 Update on the Phase 2b ASPIRE trial 09:13 How does the drug buloxibutid function? 12:22 The competitive landscape in IPF 13:55 Additional thoughts by Dr Bonella on ASPIRE trial 15:10 What can the market look out for from Vicore Pharma in 2025?
▶︎
IRLAB Therapeutics | Live 11.30 Q1 Presentation with Q&A
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Interview: Dr. William Chueh and Rahul Gupta on 10X Load Growth, Storage, and the Grid's Bottlenecks
▶︎
LeDoux: What fearful rats can tell us about treating psychiatric disorders
▶︎
The World's Most Important Machine
▶︎
Neuropeptide Y in Normal Brain Function and in Mood Disorders
▶︎
Doctor reveals undisclosed risks of COVID-19 vaccine
▶︎
Inside EMA – Episode 1: The drugs don’t work: Addressing antimicrobial resistance
▶︎
Patellofemoral pain 3 - Effective rehab that won't flare their symptoms with Tom Goom
▶︎
But what is the Fourier Transform? A visual introduction.
▶︎
2018 Nobel Lectures in Physiology or Medicine
▶︎
Catholic Mass 101: Learn Every Part of the Mass and What It Means (w/ Fr. Mike Schmitz)
▶︎
Nobel Prize lecture: Fred Ramsdell, Nobel Prize in Physiology or Medicine 2025
▶︎
Michelle Craske: Exposure Strategies - State of the Art
▶︎
Inside WRHN: A Conversation with Dr. Toby Chan | Co-division Head of Ophthalmology at WRHN
▶︎
How George Soros Broke the Bank of England
▶︎
Unlearn Negative Thoughts & Behaviors Patterns | Dr. Alok Kanojia (Healthy Gamer)
▶︎
But what is quantum computing? (Grover's Algorithm)
▶︎
Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!
▶︎